Views & Analysis A collaborative approach to greater diversity in clinical tr... The need for diversity in clinical trial populations has been a topic of discussion across regulators and the industry in general for decades.
Digital Company profile: Evidera Data disruption and applying ‘enabled intelligence’ to convert the promise shown in clinical trials into real-world success.
R&D Opening doors in pharmaceutical development Evidera surveys the adoption of machine learning by the pharmaceutical industry and looks at how it can increase R&D efficiencies.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends